SBFM Annual Short Term Debt
$118.70 K
-$4300.00-3.50%
31 December 2023
Summary:
As of January 22, 2025, SBFM annual short term debt is $118.70 thousand, with the most recent change of -$4300.00 (-3.50%) on December 31, 2023. During the last 3 years, it has fallen by -$845.40 thousand (-87.69%). SBFM annual short term debt is now -100.00% below its all-time high of $12.87 billion, reached on December 1, 2002.SBFM Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFM Quarterly Short Term Debt
$116.30 K
+$1800.00+1.57%
30 September 2024
Summary:
As of January 22, 2025, SBFM quarterly short term debt is $116.30 thousand, with the most recent change of +$1800.00 (+1.57%) on September 30, 2024. Over the past year, it has dropped by -$1500.00 (-1.27%). SBFM quarterly short term debt is now -89.80% below its all-time high of $1.14 million, reached on December 1, 2015.SBFM Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFM Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -1.3% |
| 3 y3 years | -87.7% | -4.8% |
| 5 y5 years | -82.1% | -4.8% |
SBFM Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | -5.5% | ||
| 5 y | 5-year | -87.7% | -87.9% | ||
| alltime | all time | -100.0% | -89.8% |
Sunshine Biopharma Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $116.30 K(+1.6%) |
| June 2024 | - | $114.50 K(-0.8%) |
| Mar 2024 | - | $115.40 K(-2.8%) |
| Dec 2023 | $118.70 K(-3.5%) | $118.70 K(+0.8%) |
| Sept 2023 | - | $117.80 K(-3.5%) |
| June 2023 | - | $122.10 K(+0.7%) |
| Mar 2023 | - | $121.30 K(-1.4%) |
| Dec 2022 | $123.00 K(>+9900.0%) | $123.00 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | - |
| Dec 2021 | - | $0.00(-100.0%) |
| Sept 2021 | - | $330.00 K(-30.3%) |
| June 2021 | - | $473.70 K(-28.7%) |
| Mar 2021 | - | $664.70 K(-31.1%) |
| Dec 2020 | $964.10 K(+34.7%) | $964.10 K(+46.4%) |
| Sept 2020 | - | $658.50 K(+16.0%) |
| June 2020 | - | $567.80 K(-11.5%) |
| Mar 2020 | - | $641.70 K(-10.3%) |
| Dec 2019 | $715.60 K(+8.0%) | $715.60 K(-4.8%) |
| Sept 2019 | - | $751.70 K(-3.5%) |
| June 2019 | - | $778.80 K(-13.5%) |
| Mar 2019 | - | $900.70 K(+35.9%) |
| Dec 2018 | $662.80 K(-8.3%) | $662.80 K(+10.8%) |
| Sept 2018 | - | $598.00 K(-37.9%) |
| June 2018 | - | $963.40 K(-7.9%) |
| Mar 2018 | - | $1.05 M(+44.7%) |
| Dec 2017 | $722.60 K(+204.9%) | $722.60 K(+22.1%) |
| Sept 2017 | - | $591.70 K(+46.3%) |
| June 2017 | - | $404.50 K(+58.4%) |
| Mar 2017 | - | $255.30 K(+7.7%) |
| Dec 2016 | $237.00 K | $237.00 K(-4.8%) |
| Sept 2016 | - | $249.00 K(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $324.10 K(-70.7%) |
| Mar 2016 | - | $1.10 M(-3.2%) |
| Dec 2015 | $1.14 M(+137.6%) | $1.14 M(+172.5%) |
| Sept 2015 | - | $418.60 K(+7.2%) |
| June 2015 | - | $390.60 K(+24.8%) |
| Mar 2015 | - | $313.10 K(-34.8%) |
| Dec 2014 | $480.10 K(+3740.8%) | $480.10 K(+21.2%) |
| Sept 2014 | - | $396.00 K(+40.2%) |
| June 2014 | - | $282.50 K(+113.2%) |
| Mar 2014 | - | $132.50 K(+960.0%) |
| Dec 2013 | $12.50 K(-80.0%) | $12.50 K(0.0%) |
| Sept 2013 | - | $12.50 K(0.0%) |
| June 2013 | - | $12.50 K(0.0%) |
| Mar 2013 | - | $12.50 K(-80.0%) |
| Dec 2012 | $62.50 K(>+9900.0%) | $62.50 K(+400.0%) |
| Sept 2012 | - | $12.50 K(0.0%) |
| June 2012 | - | $12.50 K(0.0%) |
| Mar 2012 | - | $12.50 K(>+9900.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| July 2009 | $31.00 K(+82.4%) | $31.00 K(+17.0%) |
| Apr 2009 | - | $26.50 K(+20.5%) |
| Jan 2009 | - | $22.00 K(0.0%) |
| Oct 2008 | - | $22.00 K(+29.4%) |
| July 2008 | $17.00 K(-100.0%) | $17.00 K(+25.9%) |
| Apr 2008 | - | $13.50 K |
| Dec 2003 | $11.03 B(-14.3%) | - |
| Dec 2002 | $12.87 B(+222.8%) | - |
| Dec 2001 | $3.99 B(+18.8%) | - |
| Dec 2000 | $3.36 B(-51.5%) | - |
| Dec 1999 | $6.92 B(-11.0%) | - |
| Dec 1998 | $7.78 B | - |
FAQ
- What is Sunshine Biopharma annual short term debt?
- What is the all time high annual short term debt for Sunshine Biopharma?
- What is Sunshine Biopharma annual short term debt year-on-year change?
- What is Sunshine Biopharma quarterly short term debt?
- What is the all time high quarterly short term debt for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly short term debt year-on-year change?
What is Sunshine Biopharma annual short term debt?
The current annual short term debt of SBFM is $118.70 K
What is the all time high annual short term debt for Sunshine Biopharma?
Sunshine Biopharma all-time high annual short term debt is $12.87 B
What is Sunshine Biopharma annual short term debt year-on-year change?
Over the past year, SBFM annual short term debt has changed by -$4300.00 (-3.50%)
What is Sunshine Biopharma quarterly short term debt?
The current quarterly short term debt of SBFM is $116.30 K
What is the all time high quarterly short term debt for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly short term debt is $1.14 M
What is Sunshine Biopharma quarterly short term debt year-on-year change?
Over the past year, SBFM quarterly short term debt has changed by -$1500.00 (-1.27%)